Cargando…
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
Bacillus anthracis and Yersinia pestis, the causative agents of anthrax and plague, respectively, are two of the deadliest pathogenic bacteria that have been used as biological warfare agents. Although Biothrax is a licensed vaccine against anthrax, no Food and Drug Administration-approved vaccine e...
Autores principales: | Tao, Pan, Mahalingam, Marthandan, Zhu, Jingen, Moayeri, Mahtab, Sha, Jian, Lawrence, William S., Leppla, Stephen H., Chopra, Ashok K., Rao, Venigalla B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191538/ https://www.ncbi.nlm.nih.gov/pubmed/30327445 http://dx.doi.org/10.1128/mBio.01926-18 |
Ejemplares similares
-
A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis
por: Tao, Pan, et al.
Publicado: (2017) -
Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines
por: Tao, Pan, et al.
Publicado: (2013) -
A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells
por: Zhu, Jingen, et al.
Publicado: (2019) -
Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
por: Zhu, Jingen, et al.
Publicado: (2023) -
Role of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor
por: Gupta, Pradeep K., et al.
Publicado: (2008)